跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 38,490 条关于
“Mucopolysaccharidosis II”
全部
38,490
临床试验
34,016
药物
288
机构
40
资讯
4,146
2年前
JCR Pharmaceuticals' JR-441 Receives Clearance for Phase I MPS IIIA Trial in Japan
7年前
Denali's Hunter Syndrome Candidate Receives FDA Orphan Drug and Rare Pediatric Disease Designations
去年
GC Biopharma's Hunterase ICV Approved in Russia for Severe Hunter Syndrome
去年
FDA Grants Orphan Drug Designation to JR-446 for Rare Neurological Disorder MPS IIIB
3年前
Ultragenyx's UX111 Gene Therapy Shows Sustained Efficacy in MPS IIIA Patients
2年前
FDA Extends Review Timeline for REGENXBIO's Hunter Syndrome Gene Therapy RGX-121
2年前
JCR Pharmaceuticals' Laronidase for Hurler Syndrome Expected to Generate $38M by 2040
去年
REGENXBIO Presents ABBV-RGX-314 Data for Wet AMD and Diabetic Retinopathy at AAO 2024
去年
Ultragenyx's UX111 Gene Therapy Shows Promise in Sanfilippo Syndrome Type A
去年
Advancements in Gene and Cell Therapies Target Diverse Diseases
第 1 页,共 415 页
上一页
下一页